• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
HealthHealth

MIT Ends Contract With Nectome, the 100% Fatal Brain Freeze Startup

By
Kirsten Korosec
Kirsten Korosec
Down Arrow Button Icon
By
Kirsten Korosec
Kirsten Korosec
Down Arrow Button Icon
April 3, 2018, 1:36 PM ET
netcome-mit-contract-brain-preserve
Brain frozen with icicles hanging off itMike Kemp Images—Getty Images

Nectome, the brain preservation startup that has raised more than $200,000 in deposits from people who want to use the 100% fatal process, has lost a contract with MIT.

MIT Media Lab terminated a subcontract with Nectome following a report by MIT Technology Review that described the company’s promotion of its technology. Nectome’s brain storage service is not yet for sale. But it has taken deposits, including one from investor and Y Combinator president Sam Altman.

Nectome is developing a brain freeze technology that it says will preserve the neurons and synapses, and in turn, the memories stored there. It’s like a digital backup for your brain that will keep it—and its contents—preserved for centuries, the company claims.

The upshot? The process will kill you. In order to preserve the brain in microscopic detail, it has to be fresh. Nectome’s pitch: connect terminal patients to life support, put them under with anesthesia, and then fill the body with a chemical embalming cocktail through the carotid arteries while the customer is still alive. Nectome’s approach is similar to physician-assisted suicide.

Nectome had received nearly $1 million in federal funding from the National Institute of Mental Health. MIT is party to a subcontract under the NIMH small business grant awarded to Nectome. MIT Media Lab Professor Ed Boyden professor and neuroscientist Edward Boyden and his team were working on an academic research project to combine aspects of Nectome’s chemistry with the Boyden group’s invention called expansion microscopy, to better visualize mouse brain circuits for basic science and research purposes.

“Such a novel chemistry could, if achieved, facilitate brain disorder drug discovery, boost basic neuroscience circuit mapping, and facilitate brain banking for future research into health and disease states,” MIT said in a statement. However, the organization has decided to terminate the subcontract after reviewing the “scientific premises underlying the company’s commercial plans, as well as certain public statements that the company has made.”

Boyden is not personally affiliated with the company Nectome, according to MIT Media Lab, an interdisciplinary research lab that encourages the unconventional mixing and matching of seemingly disparate research areas..

MIT also notes that neuroscience has not advanced to the point to know whether any brain preservation method is powerful enough to preserve all the different kinds of biomolecules related to memory and the mind. Nor is it know whether it’s even possible to recreate a person’s consciousness.

In other words, if a person’s brain is later uploaded to an avatar or computer, whose to say that it is even conscious, MIT mused.

“To understand this will require new science that represents a nonlinear jump from the neuroscience occuring today, and some people regard this as an unsolvable problem (aka the “hard problem” of consciousness),” MIT said in its statement.

About the Author
By Kirsten Korosec
See full bioRight Arrow Button Icon

Latest in Health

Best protein lead image
HealthDietary Supplements
The 8 Best Protein Powders of 2025: How to Choose, According to an RD
By Christina SnyderDecember 9, 2025
18 hours ago
Transparent Labs Creatine HMB as best creatine
HealthDietary Supplements
The Best Creatine Supplements of 2025: Tested and Approved
By Christina SnyderDecember 9, 2025
18 hours ago
Jon Rosemberg
CommentaryProductivity
The cult of productivity is killing us
By Jon RosembergDecember 9, 2025
22 hours ago
Trump
CommentaryTariffs and trade
AI doctors will be good at science but bad at business, and big talk with little action means even higher drugs prices: 10 healthcare predictions for 2026 from top investors
By Bob Kocher, Bryan Roberts and Siobhan Nolan ManginiDecember 9, 2025
22 hours ago
Kevin Kiley
PoliticsElections
‘It absolutely matters politically’: Swing-district Republicans alarmed at spiking health insurance premiums tipping midterms
By Marc Levy, Kevin Freking and The Associated PressDecember 8, 2025
2 days ago
HealthHealth
These toxic wild mushrooms have caused a deadly outbreak of poisoning in California
By The Associated PressDecember 7, 2025
3 days ago

Most Popular

placeholder alt text
Economy
‘Fodder for a recession’: Top economist Mark Zandi warns about so many Americans ‘already living on the financial edge’ in a K-shaped economy 
By Eva RoytburgDecember 9, 2025
14 hours ago
placeholder alt text
Success
When David Ellison was 13, his billionaire father Larry bought him a plane. He competed in air shows before leaving it to become a Hollywood executive
By Dave SmithDecember 9, 2025
1 day ago
placeholder alt text
Banking
Jamie Dimon taps Jeff Bezos, Michael Dell, and Ford CEO Jim Farley to advise JPMorgan's $1.5 trillion national security initiative
By Nino PaoliDecember 9, 2025
16 hours ago
placeholder alt text
Uncategorized
Transforming customer support through intelligent AI operations
By Lauren ChomiukNovember 26, 2025
14 days ago
placeholder alt text
Real Estate
The 'Great Housing Reset' is coming: Income growth will outpace home-price growth in 2026, Redfin forecasts
By Nino PaoliDecember 6, 2025
4 days ago
placeholder alt text
Success
Craigslist founder signs the Giving Pledge, and his fortune will go to military families, fighting cyberattacks—and a pigeon rescue
By Sydney LakeDecember 8, 2025
2 days ago
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.